Aerie Pharma (AERI) Lower with Feuerstein Out Negative

September 21, 2016 9:31 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Recent momentum stock Aerie Pharma (NASDAQ: AERI) is down 5% in pre-open trade after TheStreet's Adam Feuerstein made cautious comments on the stock.

According to Feuerstein, the company produced positive clinical trial results after enrolling patients with only borderline glaucoma.


Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Momentum Movers, Trader Talk

Related Entities

Pre Market Movers, Adam Feuerstein

Add Your Comment